# The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer

> **NCT00619242** · NA · TERMINATED · sponsor: **University of Chicago** · enrollment: 3 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** sorafenib

## Key facts

- **NCT ID:** NCT00619242
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2014-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619242, "The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00619242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*